Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-055903
Filing Date
2009-12-08
Accepted
2009-12-08 13:34:10
Documents
1
Period of Report
2009-12-04

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c93475_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c93475_4x0.xml 4 6555
  Complete submission text file 0001209191-09-055903.txt   8384
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CARE CAPITAL LLC 47 HULFISH ST., SUITE 310 PRINCETON NJ 08542
Business Address
Ramsay David Russ (Reporting) CIK: 0001352876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 091228209